Role of the Lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 629-633

  La Torre, Marco ^a   Cavallini, Marco ^a   Ramacciato, Giovanni ^a   Cosenza, Giulia ^a   Del Monte, Simone Rossi ^a   Nigri, Giuseppe ^a   Ferri, Mario ^a   Mercantini, Paolo ^a   Ziparo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

lymph node ratio; pancreatic adenocarcinoma; prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE INTERVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE RATIO; LYMPHADENOPATHY; LYMPHATIC PARAMETERS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OPERATION DURATION; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80053608522     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22013     Document Type: Article

References (22)

1. AIRTUM Working Group: Cancer incidence and mortality trends of the Italian Network of Cancer Registries (AIRTUM), 1998-2005. Rivista dell'Associazione Italiana di Epidemiologia 2009.
2. Winter JM, Cameron JL, Campbell KA, et al.: 1423 pancreaticoduodenectomies for pancreatic cancer: A single institution experience. J Gastrointest Surg 2006; 10: 1199-1210.
3. Brennan MF, Kattan MW, Klimstra D, et al.: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004; 240: 293-298. (Pubitemid 38963021)
4. Sohn TA, Yeo CJ, Cameron JL, et al.: Resected adenocarcinoma of the pancreasâ616 patients: Results:, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579.
5. Riediger H, Makowiec F, Fischer E, et al.: Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 2006; 10: 1106-1115. (Pubitemid 44332981)
6. Bando E, Yonemura Y, Taniguchi K, et al.: Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002; 9: 775-784. 18.
7. Ichikura T, Ogawa T, Chochi K, et al.: Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma. World J Surg 2003; 27: 330-333. (Pubitemid 36920146)
8. Bhatti I, Peacock O, Awan AK, et al.: Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World J Surg 2010; 34: 768-775.
9. Riediger H, Keck T, Wellner U, et al.: The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 2009; 13: 1337-1344.
10. Pawlik TM, Gleisner AL, Cameron JL, et al.: Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141: 610-618. (Pubitemid 46616937)
11. Sierzega M, Popiela T, Kulig J, et al.: The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 2006; 33: 240-245. (Pubitemid 44470138)
12. Slidell MB, Chang DC, Cameron JL, et al.: Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: A large, population-based analysis. Ann Surg Oncol 2008; 15: 165-174.
13. Bassi C, Dervenis C, Butturini G, et al.: International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 2005; 138: 8-13. (Pubitemid 40933766)
14. Sobin LH, Wittekind C,: TNM classification of malignant tumours (DICC), 6th edition. New York: John Wiley & Sons; 2002.
15. Kaplan EL, Meier P,: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Mantel N,: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
17. House MG, Gonen M, Jarnagin WR, et al.: Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 2007; 11: 1549-1555.
18. Ueda M, Endo I, Nakashima M, et al.: Prognostic factors after resection of pancreatic cancer. World J Surg 2009; 33: 104-110.
19. Berger AC, Watson JC, Ross EA, et al.: The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 2004; 70: 235-240.
20. Rosenberg R, Friederichs J, Schuster T, et al.: Prognosis of patients with colorectal cancer is associated with lymph node ratio: A single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 2008; 248: 968-978.
21. Sun Z, Zhu GL, Lu C, et al.: The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: Results: from a Chinese mono-institutional study in 2159 patients. Ann Oncol 2009; 20: 897-905.
22. Inoue K, Nakane Y, Iiyama H, et al.: The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002; 9: 27-34. (Pubitemid 34262894)